4 à 8 comprimés dragéifiés par jour répartis en 3 ou 4 administrations. Une fois la dose optimale déterminée, l'effet du médicament se prolonge durant la nuit. Sujet âgé : il n'y a pas de ...
Nearly 90% of patients with FSHD who developed myasthenia gravis (MG) improved with treatment, according to a new systematic ...
MORE than 200 medicines have remained in short supply for yet another month amid a major drug crisis affecting the UK. From blood pressure pills to HRT and ADHD drugs, some medications have now ...
BRITS are continuing to face some of the “most severe” shortages of NHS medicines on record. Earlier this week, officials sounded the alarm over two drugs, one to prevent strokes and the other to ...
A healthy diet is important for a healthy life, but it can be difficult to manage for people with a chronic disease like myasthenia gravis (MG). The neuromuscular disorder causes severe fatigue and ...
Myasthenia gravis symptoms can typically worse at the end of the day, in hot weather, during or in the interim phase post an infection or during menstruation. Pyridostigmine is a first line treatment ...
Pyridostigmine works by inhibiting the enzyme acetylcholinesterase (enzyme that breaks down acetylcholine), which is responsible for breaking down acetylcholine in the body. By blocking this enzyme, ...
Low-dose pyridostigmine is an effective treatment for men with underactive bladder who undergo TURP for BPH with BOO, trial findings suggest. Administration of pyridostigmine following transurethral ...
Mestinon (pyridostigmine bromide) is a brand-name drug prescribed for myasthenia gravis in adults. Common side effects include muscle cramps and digestive issues, but these are usually temporary.
UNDERACTIVE bladder (UAB) is marked by weak and/or brief detrusor contractions, leading to incomplete emptying. Prolonged bladder outlet obstruction (BOO), most commonly from benign prostatic ...
Bladder outlet obstruction mediated underactive bladder represents a challenging condition in which transurethral resection of prostate did not prove to be a sufficient treatment option. Therefore, ...